Clinical implications of bronchoalveolar lavage fluid cellular analysis in fibrotic interstitial lung disease combined with CT quantification
Therapeutic Advances in Respiratory Disease · 2025
DOI: 10.1177/17534666251393075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2025. Verfasst von Bora Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary, Critical Care and Sleep Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seou…. Hauptthemen laut MEDLINE: Bronchoalveolar Lavage Fluid, Tomography, X-Ray Computed, Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Foundation for the Advancement of Science and Creativity, Asan Institute for Life Sciences, Asan Medical Center.
Abstract (Originalsprache)
Background
Although the clinical role of bronchoalveolar lavage (BAL) in interstitial lung disease (ILD) has been suggested by previous studies, its clinical utility remains debatable.
Objectives
We aimed to evaluate the clinical implications of combining quantitative computed tomography (QCT) and BAL fluid cellular analysis in patients with fibrotic ILD.
Design
This study was a retrospective, single-center study.
Methods
We analyzed patients with fibrotic ILD who underwent BAL in specific lung locations and used deep-learning-based QCT. Correlations between BAL cellular components and QCT parameters were assessed for both the whole lung and the tested lobe, and survival outcomes and disease progression were evaluated.
Results
Among 163 patients, no significant difference was observed in BAL cellular analysis between radiologic usual interstitial pneumonia (UIP) and non-UIP groups (for all, p > 0.05). BAL neutrophil levels showed weak positive correlation with fibrosis score (whole lung: r = 0.308, p < 0.001; tested lobe: r = 0.200; p = 0.010). While BAL cellular analysis alone showed no difference in 3-year survival, a high fibrosis score (⩾20%) independently predicted 3-year mortality (hazard ratio 4.62, p = 0.002). In patients with fibrosis score ⩾10%, high BAL neutrophils (>4.5%) indicated greater 1-year fibrosis progression (log-rank test, p = 0.029). In steroid-treated patients, BAL lymphocytosis (⩾15%) was associated with a trend toward an improved prognosis ( p = 0.073); however, within this group, those with fibrosis scores ⩾20% had worse outcomes in the 3-year survival rate (median survival: 16.4 months vs not reached, p = 0.039).
Conclusion
Although BAL fluid cellular analysis alone does not differentiate radiologic patterns or offer prognostic values, elevated BAL neutrophil levels combined with a high fibrosis score on CT may help to identify patients at higher risk of early fibrosis progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary, Critical Care and Sleep Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
ORCID-Profile: Bora Lee, Hyun Seok Kwak, Jang Ho Lee, Ho Cheol Kim
Förderung
- Korea Foundation for the Advancement of Science and Creativity
- Asan Institute for Life Sciences, Asan Medical Center
Zitieren
APA
Lee, B., Kwak, H. S., Cho, H. S., Lee, J. H., Seo, J. B., Choe, J., & Kim, H. C. (2025). Clinical implications of bronchoalveolar lavage fluid cellular analysis in fibrotic interstitial lung disease combined with CT quantification. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666251393075
Vancouver
Lee B, Kwak HS, Cho HS, Lee JH, Seo JB, Choe J, et al. Clinical implications of bronchoalveolar lavage fluid cellular analysis in fibrotic interstitial lung disease combined with CT quantification. Therapeutic Advances in Respiratory Disease. 2025. doi:10.1177/17534666251393075
BibTeX
@article{Lee2025,
author = {Lee, Bora and Kwak, Hyun Seok and Cho, Hyo Sin and Lee, Jang Ho and Seo, Joon Beom and Choe, Jooae and Kim, Ho Cheol},
title = {Clinical implications of bronchoalveolar lavage fluid cellular analysis in fibrotic interstitial lung disease combined with CT quantification},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2025},
doi = {10.1177/17534666251393075}
}
EUVIMED